SearchDictionaryMobileLogin Register FREE

bis(perfluorobutyl)ethene

Subscribe to Selected New Research on bis(perfluorobutyl)ethene
4  relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent
Also Known As:
(E)-isomer of bis(perfluorobutyl)ethene; (Z)-isomer of bis(perfluorobutyl)ethene; 1,2-bis(perfluorobutyl)ethylene; F-44E; F44E; bis(F-butyl)ethene; bis-PFBE; bis-perfluorobutylethene; bis-perfluorobutylethylene; therox; 5-Decene, 1,1,1,2,2,3,3,4,4,7,7,8,8,9,9,10,10,10-octadecafluoro-

Bio-Agent Context: Research Results

-
Organic Chemicals: 40
-
Hydrocarbons: 382
-
Halogenated Hydrocarbons: 28
-
Fluorinated Hydrocarbons: 2
-
Fluorocarbons: 127
*
bis(perfluorobutyl)ethene: 4

Related Diseases

1. Neoplasms (Cancer)
05/15/1989 - "This was true whether administered as a 48% (v/v) emulsion in 0.1 ml or as a 16% (v/v) emulsion in 0.3 ml. When the injection volume was varied from 0.1 ml to 0.4 ml at the 4 g/kg or 6 g/kg dose, thereby varying the emulsion concentration from 48% (v/v) to 12% (v/v) or 18% (v/v), the results tended to indicate that the volume of injection may be more important than the emulsion concentration, i.e., an injection volume of 0.2 ml produced the greatest tumor growth delay for both doses, and the emulsion concentration of 0.2 ml and 4 g/kg of F44E is 24% (v/v) whereas the emulsion concentration of 0.2 ml and 6 g/kg of F44E is 36% (v/v)"
05/15/1989 - "The enhancement in tumor growth delay with single dose radiation therapy increased as the dose of F44E was increased from 1.2 g/kg (0.03 ml) to 4 g/kg (0.1 ml)"
05/15/1989 - "However, when the F44E emulsion was administered every day with fractionated radiation and carbogen breathing, there was a marked enhancement in tumor growth delay observed across the entire dosage range, from 1.2 g/kg to 12 g/kg.(ABSTRACT TRUNCATED AT 400 WORDS)"
05/15/1989 - "When F44E was administered on treatment Days 1, 3, and 5 with carbogen breathing, there was an increased effect on tumor growth delay which reached a maximum at 4 g/kg (0.1 ml) of 10.0 +/- 1.2 days compared with 6.7 +/- 1.0 days for radiation with daily carbogen breathing"
05/15/1989 - "We have examined the effects of a wide range of levels of Therox, a perfluorochemical emulsion containing bis-perfluorobutyl ethylene (F44E) with carbogen breathing on the tumor growth delay of the Lewis lung carcinoma produced by single dose radiation and fractionated radiation"
Get all the results and reference details, order at left...
2. Lewis Lung Carcinoma
3. Thrombosis (Thrombus)
4. Brain Ischemia (Cerebral Ischemia)
4 Diseases and 4 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1. bis(perfluorobutyl)ethene
2. carbogen
3. GTP-Binding Proteins (G-Protein)
4. Oxygen
5. Hemoglobins (Hemoglobin)
6. Emulsions
7. ethylene
8. Fluosol-DA
8 Drugs and Important Bio-Agents and 3 more articles analyzed in the Research Interface, order at left...

Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License details >>
Price:$490.00 access via web interface, 1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m", 1 year subscription
Proceed to Checkout >>